COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 181 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,001 | +4.0% | 358 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7,693 | -10.4% | 358 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $8,588 | +35.6% | 358 | +31.1% | 0.01% | +25.0% |
| Q4 2022 | $6,334 | +26.7% | 273 | -20.4% | 0.00% | +33.3% |
| Q3 2022 | $5,000 | -16.7% | 343 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $6,000 | +50.0% | 343 | +61.8% | 0.00% | +100.0% |
| Q4 2021 | $4,000 | 0.0% | 212 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | -20.0% | 212 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $5,000 | 0.0% | 212 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | +25.0% | 212 | -10.9% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | 0.0% | 238 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $4,000 | -20.0% | 238 | -42.1% | 0.00% | +33.3% |
| Q3 2019 | $5,000 | -16.7% | 411 | -8.3% | 0.00% | -25.0% |
| Q2 2019 | $6,000 | -14.3% | 448 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $7,000 | 0.0% | 448 | -3.9% | 0.01% | +66.7% |
| Q3 2018 | $7,000 | – | 466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $48,689,000 | 2.30% |
| Camber Capital Management LP | 1,050,000 | $19,614,000 | 0.67% |
| OneAscent Wealth Management LLC | 14,131 | $264,000 | 0.66% |
| Eventide Asset Management | 2,629,593 | $49,121,000 | 0.63% |
| CLARK ESTATES INC/NY | 183,800 | $3,433,000 | 0.50% |
| Values First Advisors, Inc. | 42,312 | $790,000 | 0.47% |
| RICE HALL JAMES & ASSOCIATES, LLC | 704,201 | $13,154,000 | 0.47% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 650,398 | $12,149,000 | 0.43% |
| OneAscent Financial Services LLC | 11,774 | $220,000 | 0.42% |
| Factorial Partners, LLC | 33,300 | $622,000 | 0.41% |